"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary ...

For years, federal health officials have told most Americans to expect annual updates to COVID-19 vaccines, similar to the ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift ...

Regulators will soon “unleash a massive framework” for how vaccines are tested and approved, according to FDA Commissioner ...

On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.